Red Cell Survival
Showing 1 - 25 of >10,000
Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood
Recruiting
- Sickle Cell Disease Without Crisis
- G6PD Deficient Red Blood Cell Transfusion
- Non-G6PD deficient Red Blood Cell Transfusion
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Aug 15, 2022
Sickle Cell Disease Trial in Atlanta (Biotin Labeled Red Blood Cells)
Recruiting
- Sickle Cell Disease
- Biotin Labeled Red Blood Cells
-
Atlanta, Georgia
- +2 more
Nov 1, 2021
Diabetes, Red Blood Cell Survival Trial in Iowa City (biotin labeled RBCs)
Completed
- Diabetes
- Red Blood Cell Survival
- biotin labeled RBCs
-
Iowa City, IowaUniversity of Iowa
Feb 4, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Red Blood Cell Transfusion, Oxygen Consumption Trial in Izmir (No intervention group.)
Not yet recruiting
- Red Blood Cell Transfusion
- Oxygen Consumption
- No intervention group.
-
Izmir, TurkeyIzmir Katip Celebi University Ataturk Training and Research Hosp
Mar 22, 2023
Anemia Trial in Atlanta (Biotin-Labeled Red Blood Cells (RBCs))
Recruiting
- Anemia
- Biotin-Labeled Red Blood Cells (RBCs)
-
Atlanta, GeorgiaEmory University
Jan 26, 2022
Anemia, Age Problem, Ultrasonography Trial in Nîmes (transthoracic echocardiography)
Not yet recruiting
- Anemia
- +2 more
- transthoracic echocardiography
-
Nîmes, Gard, FranceCHU de Nîmes
Sep 25, 2023
Pancreatic Diseases Trial in Shanghai (Red cell lysis buffer (RCLB) application, Conventional processing)
Not yet recruiting
- Pancreatic Diseases
- Red cell lysis buffer (RCLB) application
- Conventional processing
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jul 12, 2023
Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication Trial (Red Blood Cell Transfusion)
Not yet recruiting
- Blood Loss Anemia
- Extracorporeal Membrane Oxygenation Complication
- Red Blood Cell Transfusion
- (no location specified)
Apr 3, 2023
Width and Lactate Albumin Ratio as Prognostic Markers for
Not yet recruiting
- Morality
- +2 more
- Red cell distribution width
- lactate albumin ratio measurement
-
Tanta, Elgharbia, EgyptTanta University Hospitals
Jun 18, 2023
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution
Recruiting
- Polycythemia Vera
-
Sohag, EgyptFaculty of Medicine
Aug 12, 2023
Platelet and Red Blood Cell Volume Indices as Inflammatory
Recruiting
- Ankylosing Spondylitis
- CBC
-
Sohag, EgyptSohag university Hospital
Aug 10, 2023
Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age Trial in United States (Liberal
Active, not recruiting
- Infant, Newborn, Diseases
- +4 more
- Liberal Cell Transfusion
- Restricted red cell transfusion
-
Birmingham, Alabama
- +19 more
Jan 18, 2022
Study of a Deformability Parameter of Red Blood Cell
Not yet recruiting
- Drepanocytosis
- basal blood collection
- +2 more
- (no location specified)
May 10, 2023
Polycythemia Trial (CO-Rebreathing technique at diagnosis of polycythemia)
Completed
- Polycythemia
- CO-Rebreathing technique at diagnosis of polycythemia
-
Amiens, Picardie, FranceCHU Amiens Picardie
Jan 17, 2023
Malignant Ovarian Germ Cell Tumors
Recruiting
- Fertility Issues
- observational study
-
Cairo, EgyptDepartment of Obstetrics & Gynecology
Jun 7, 2023
Red Blood Cell Disorder, Oxidative Stress, Iron Metabolism Disorders Trial in Poznan (THYROX (Atlantic krill oil)., Placebo)
Recruiting
- Red Blood Cell Disorder
- +2 more
- THYROX (Atlantic krill oil).
- Placebo
-
Poznań, PolandPoznań University of Physical Education
Nov 21, 2023
Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)
Recruiting
- Cancer
- +2 more
- engineered red blood cell WTX212
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Jan 21, 2023
Multiple Myeloma Prognostic Indices
Recruiting
- Multiple Myeloma
- Hematologic Diseases
- blood viscosity , albumin / fibrinogen ratio and red cell distribution
-
Assiut, EgyptAssiut University hospital
Oct 17, 2023
Resectable Pancreatic Carcinoma Trial (biological, procedure, other)
Not yet recruiting
- Resectable Pancreatic Carcinoma
- Arm I Packed Red Blood Cell Transfusion (Hgb < 7 g/dL)
- +6 more
- (no location specified)
Apr 24, 2023
Individualized Transfusion Strategy, Red Blood Cell, Perioperative Pediatric Patient Trial (clinical condition score)
Withdrawn
- Individualized Transfusion Strategy
- +3 more
- clinical condition score
- (no location specified)
Aug 4, 2022
Following Salvage Surgery for RESidual or reCurrent sqUamous
Not yet recruiting
- Head and Neck Cancer
- Molecular Analyses
- (no location specified)
Mar 28, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Health Promotion and Education
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 24, 2023
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Diamond Blackfan Anemia, Pure Red Cell Aplasia Trial in Boston, Manhasset (Trifluoperazine)
Terminated
- Diamond Blackfan Anemia
- Pure Red Cell Aplasia
-
Boston, Massachusetts
- +1 more
Nov 18, 2022